Find More Contacts for Sutro Biopharma
Protected Content
General Counsel
Executive Management
1 email found
View contacts for Sutro Biopharma to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email general@sutrobio.com
  • Phone Number 650-392-8412

Sutro Biopharma is a clinical stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF.

Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.

Lists Featuring This Company

Information Technology Public Companies With Less Than $1B in Revenue
1,031 Number of Organizations â€¢ $70.4B Total Funding Amount â€¢ 1,918 Number of Investors
Tekla Capital Management Portfolio Companies
42 Number of Organizations â€¢ $8.6B Total Funding Amount â€¢ 527 Number of Investors
Information Technology Companies With Less Than $500M in Revenue (Top 10K)
9,828 Number of Organizations â€¢ $394.3B Total Funding Amount â€¢ 49,757 Number of Investors
San Francisco Bay Area Companies With More Than 10 Employees (Top 10K)
10,000 Number of Organizations â€¢ $1T Total Funding Amount â€¢ 71,311 Number of Investors

Frequently Asked Questions

Where is Sutro Biopharma's headquarters? Sutro Biopharma is located in South San Francisco, California, United States.Who invested in Sutro Biopharma? Sutro Biopharma has 19 investors including Blackstone Life Sciences and Frazier Healthcare Partners.How much funding has Sutro Biopharma raised to date? Sutro Biopharma has raised .When was the last funding round for Sutro Biopharma? Sutro Biopharma closed its last funding round on Jun 26, 2023 from a Post-IPO Debt round.Who are Sutro Biopharma's competitors? Alternatives and possible competitors to Sutro Biopharma may include Scholar RockAgenus, and Slingshot Biosciences.